Abstract:Reactive Oxygen Species (ROS)‐regulating nanomedicines for disease treatments mainly include ROS‐upregulating nanomedicines and ROS‐downregulating nanomedicines. Here, ROS‐upregulating nanomedicines can exert the toxic effect by employing nanoplatforms to enhance ROS generation in pathological sites for ROS‐induced toxic therapy, and ROS‐downregulating nanomedicines can scavenge excess ROS to maintain normal physiological process and avoid oxidative stress injuries for antioxidant therapy.Reactive oxygen species (ROS) play an essential role in physiological and pathological processes. Studies on the regulation of ROS for disease treatments have caused wide concern, mainly involving the topics in ROS‐regulating therapy such as antioxidant therapy triggered by ROS scavengers and ROS‐induced toxic therapy mediated by ROS‐elevation agents. Benefiting from the remarkable advances of nanotechnology, a large number of nanomaterials with the ROS‐regulating ability are developed to seek new and effective ROS‐related nanotherapeutic modalities or nanomedicines. Although considerable achievements have been made in ROS‐based nanomedicines for disease treatments, some fundamental but key questions such as the rational design principle for ROS‐related nanomaterials are held in low regard. Here, the design principle can serve as the initial framework for scientists and technicians to design and optimize the ROS‐regulating nanomedicines, thereby minimizing the gap of nanomedicines for biomedical application during the design stage. Herein, an overview of the current progress of ROS‐associated nanomedicines in disease treatments is summarized. And then, by particularly addressing these known strategies in ROS‐associated therapy, several fundamental and key principles for the design of ROS‐associated nanomedicines are presented. Finally, future perspectives are also discussed in depth for the development of ROS‐associated nanomedicines.

Reactive oxygen species-scavenging biomaterials for neural regenerative medicine

Reactive Oxygen Species-Responsive Nanotherapy for the Prevention and Treatment of Cerebral Ischemia–reperfusion Injury

Reactive Oxygen Species-Based Biomaterials for Regenerative Medicine and Tissue Engineering Applications

Reactive oxygen species-sensitive materials: A promising strategy for regulating inflammation and favoring tissue regeneration

Bioactive ROS‐scavenging Nanozymes for Regenerative Medicine: Reestablishing the Antioxidant Firewall

Reactive Oxygen Species (Ros)-Responsive Biomaterials Mediate Tissue Microenvironments and Tissue Regeneration

Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: from mechanism to therapy

Reactive Oxygen Species-Responsive Composite Fibers Regulate Oxidative Metabolism through Internal and External Factors to Promote the Recovery of Nerve Function

Reactive Oxide Species-Scavenging Lipid-Polymer Nanoparticles for Neuroprotection after Spinal Cord Injury

Biomedical Application of Reactive Oxygen Species–Responsive Nanocarriers in Cancer, Inflammation, and Neurodegenerative Diseases

Application and Prospect of ROS-related Nanomaterials for Orthopaedic Related Diseases Treatment

Recent antioxidative nanomaterials toward wound dressing and disease treatment via ROS scavenging

Nanozymes: Potential Therapies for Reactive Oxygen Species Overproduction and Inflammation in Ischemic Stroke and Traumatic Brain Injury

Reactive Oxygen Species and Neurodegenerative Diseases: Insights into Nanozyme Therapeutics

Reactive Oxygen Species (ROS)-Based Nanomedicine.

Reactive oxygen species (ROS)-responsive biomaterials for treating myocardial ischemia-reperfusion injury

ROS: Executioner of regulating cell death in spinal cord injury

Nanozyme Hydrogels Promote Nerve Regeneration in Spinal Cord Injury by Reducing Oxidative Stress

Utilizing reactive oxygen species-scavenging nanoparticles for targeting oxidative stress in the treatment of ischemic stroke: A review

ROS Regulation in CNS Disorder Therapy: Unveiling the Dual Roles of Nanomedicine

Reactive Oxygen Species‐Regulating Strategies Based on Nanomaterials for Disease Treatment